Sports Supplement

No Xplode

38 adverse event reports submitted to the FDA · 2005–2019 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 38 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Rhabdomyolysis
5
Dizziness
5
Blood Creatinine Increased
4
Hepatic Enzyme Increased
4
Jaundice
4
Pruritus
4
Renal Failure
4
Dyspnoea
4
Paraesthesia
4
Alanine aminotransferase increased
4

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Hospitalization 23
Other Serious or Important Medical Event 13
Visited a Health Care Provider 7
Visited Emergency Room 7
Life Threatening 5
Other Serious Outcome 4
Required Intervention 3
Other Outcome 2
Death 2
Disability 1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
7
18–34
18
35–49
5
50–64
3
65–79
0
80+
0
Unknown
5

33 reports had age data; 5 unknown.

Gender

Male
37
Female
1
Unknown/Not Reported
0

Reports by Year

Annual report counts from 2005–2019. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Hover bars for exact counts.

Context about this data: Reports concentrated in 2009 (47% of total, spanning 2005–2019), suggesting a reporting event during that period rather than evenly distributed consumer use.

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data